LENSAR, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
LENSAR, INC. (LNSR) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 4.40% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2026-08-13
- LENSAR, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2025-03-31 was 4.40%, a 4.76% increase year-over-year.
- LENSAR, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2024-09-30 was 4.40%, a 2.33% increase year-over-year.
- LENSAR, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2024-06-30 was 4.60%, a 17.95% increase year-over-year.
- LENSAR, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2024-03-31 was 4.20%, a 0.00% change year-over-year.
- LENSAR, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2025 was 4.40%, a 4.35% decline from fiscal 2024.
- LENSAR, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2024 was 4.60%, a 2.13% decline from fiscal 2023.
- LENSAR, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2023 was 4.70%, a 11.90% increase from fiscal 2022.
- LENSAR, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2022 was 4.20%, a 223.08% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month |
|---|---|---|---|---|
| 2025-12-31 | 4.40% 10-K · filed 2026-03-31 | |||
| 2025-09-30 | 4.40% 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 4.40% 10-Q · filed 2026-08-13 | |||
| 2025-03-31 | 4.40% 10-Q · filed 2026-05-08 | |||
| 2024-12-31 | 4.60% 10-K · filed 2026-03-31 | |||
| 2024-09-30 | 4.40% 10-Q · filed 2025-11-06 | 4.60% 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | 4.60% 10-Q · filed 2025-08-07 | 4.60% 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | 4.20% 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | 4.70% 10-K · filed 2025-02-27 | |||
| 2023-09-30 | 4.30% 10-Q · filed 2024-11-07 | 4.30% 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | 3.90% 10-Q · filed 2024-08-08 | 4.20% 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | 4.20% 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | 4.20% 10-K · filed 2024-03-04 | |||
| 2022-09-30 | 3.40% 10-Q · filed 2023-11-09 | 3.40% 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | 3.00% 10-Q · filed 2023-08-09 | 3.00% 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | 1.60% 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | 1.30% 10-K · filed 2023-03-16 | |||
| 2021-09-30 | 1.10% 10-Q · filed 2022-11-09 | 1.10% 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | 1.10% 10-Q · filed 2022-08-08 | |||
| 2021-03-31 | 1.10% 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |